Chinese Scientists Collaborate On New AIDS Vaccine
This article was originally published in PharmAsia News
Executive Summary
Hong Kong and Mainland China scientists are concentrating on three particular variants of HIV common among people in West China, Hong Kong and Taiwan to develop an AIDS vaccine. The scientists are basing their work on a collaborative effort by Chinese and U.S. researchers who designed a vaccine based on two of the HIV variants. The director of the new AIDS Institute in Hong Kong said the hope is the designed vaccine treating the two variants spread among drug users also will work on the third variant, spread through sex. (Click here for more
You may also be interested in...
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.